Dear patients and friends,
At GUA Urology and Andrology, we are committed to ensuring that you receive the safest and most effective medical care available. That is why we would like to inform you of an important update to our diagnostic procedure for prostate cancer.
For several years, our GUA Urology and Andrology center has implemented transperineal biopsy as the standard for prostate cancer screening, a practice that has proven to be significantly safer compared to transrectal biopsies. The latest European Urology Guidelines 2024 endorse this practice, noting that transperineal biopsies significantly reduce the risk of infectious complications, including sepsis.
Based on these guidelines and our clinical experience, we confirm the complete cessation of transrectal biopsies at our center in order to protect your health and ensure the best diagnostic results.
We understand that changes like this may raise questions. Please do not hesitate to contact us if you would like more information.
Thank you for trusting GUA Urology and Andrology for your urological care.
Sincerely yours,
The address
